Home
Mail
TV
News
Sport
Finance
Lifestyle
Entertainment
Weather
Mobile
Yahoo
Mail
Cost Of Living
Watchlists
My Portfolios
Markets
Money
Work
Technology
Industries
Give Feedback
Australia markets open in 40 minutes
ALL ORDS
8,019.40
-3.30
(-0.04%)
AUD/USD
0.6610
+0.0001
(+0.02%)
ASX 200
7,750.00
+1.00
(+0.01%)
OIL
79.16
+0.04
(+0.05%)
GOLD
2,344.00
+1.00
(+0.04%)
Bitcoin AUD
95,110.02
+2,199.08
(+2.37%)
Navidea Biopharmaceuticals, Inc. (NAVB)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0350
-0.0010
(-2.78%)
At close: 01:38PM EDT
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
0.61
14.645
45.615
118.725
Cost of revenue
50.036
184.947
0
1.048
Gross profit
-49.426
-170.302
45.615
117.677
Operating expenses
Research development
5,093
5,970
5,142
4,930
Selling general and administrative
5,037
7,962
7,450
6,695
Total operating expenses
10,130
13,881
12,106
10,829
Operating income or loss
-10,180
-14,051
-12,060
-10,711
Interest expense
-
1,098
6.361
-
Total other income/expenses net
1,569
-27.939
351.885
-21.854
Income before tax
-8,607
-15,177
-11,715
-10,722
Income tax expense
-
0
16.043
0
Income from continuing operations
-8,607
-15,177
-11,731
-10,722
Net income
-1,182
-15,177
-11,731
-10,722
Net income available to common shareholders
-1,389
-17,215
-11,731
-11,386
Basic EPS
-0.08
-0.56
-0.40
-0.48
Diluted EPS
-0.08
-0.56
-0.40
-0.48
Basic average shares
53,347
30,902
29,344
23,896
Diluted average shares
53,347
30,902
29,344
23,896
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.